1. Blocking Metallothionein-2 Expression by Copper-Doped Carbon Dots Induces Cellular Antioxidant System Collapse for Antitumor Therapy.
- Author
-
Liu K, Liu X, Wen L, Zhai W, Ye R, Zhang B, Xie W, Zhang X, Zhang W, Li H, Xu J, Huang L, Wang H, Li D, and Sun H
- Subjects
- Humans, Animals, Mice, Cell Line, Tumor, Oxidative Stress drug effects, Reactive Oxygen Species metabolism, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry, Neoplasms drug therapy, Neoplasms metabolism, Metallothionein genetics, Metallothionein metabolism, Copper chemistry, Copper pharmacology, Carbon chemistry, Carbon pharmacology, Antioxidants pharmacology, Antioxidants chemistry, Quantum Dots chemistry, Quantum Dots therapeutic use
- Abstract
The insufficient antioxidant reserves in tumor cells play a critical role in reactive oxygen species (ROS)-mediated therapeutics. Metallothionein-2 (MT-2), an intracellular cysteine-rich protein renowned for its potent antioxidant properties, is intricately involved in tumor development and correlates with a poor prognosis. Consequently, MT-2 emerges as a promising target for tumor therapy. Herein, we present the development of copper-doped carbon dots (Cu-CDs) to target MT-2 to compromise the delicate antioxidant reserves in tumor cells. These Cu-CDs with high tumor accumulation and prolonged body retention can effectively suppress tumor growth by inducing oxidative stress. Transcriptome sequencing unveils a significant decrease in MT-2 expression within the in vivo tumor samples. Further mechanical investigations demonstrate that the antitumor effect of Cu-CDs is intricately linked to apolipoprotein E (ApoE)-mediated downregulation of MT-2 expression and the collapse of the antioxidant system. The robust antitumor efficacy of Cu-CDs provides invaluable insights into developing MT-2-targeted nanomedicine for cancer therapies.
- Published
- 2024
- Full Text
- View/download PDF